MedPath

The Effect of Manual Lymph Drainage in the Treatment of Breast Edema

Not Applicable
Completed
Conditions
Breast Cancer and Rehabilitation
Interventions
Other: Education, compression and exercise therapy
Other: Education, compression and exercise therapy manual lymph drainage
Registration Number
NCT05240235
Lead Sponsor
Acibadem University
Brief Summary

Breast conserving surgery (BCS) is widely used in the treatment of breast cancer. Breast edema can be seen frequently after BCS and radiotherapy applications. Breast edema affects quality of life and may result in a cosmetically unsatisfactory outcome for the patient. Therefore, it is important to treat and prevent its development. In the light of this information, the present randomized controlled study aims to determine the effect of manual lymph drainage method in the treatment of breast edema in patients undergoing breast-conserving surgery and adjuvant radiotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
36
Inclusion Criteria
  1. Patients who underwent breast-conserving surgery and received adjuvant radiotherapy
  2. Patients with Sentinel Lymph Node Biopsy or axillary lymph node dissection
  3. Female patients between the ages of 18-75
  4. Patients who cannot read and write Turkish
Exclusion Criteria
  1. A previous cancer
  2. Decompensated heart failure
  3. Untreated congestive heart failure
  4. Active infection
  5. Uncontrolled hypertension
  6. Acute kidney failure
  7. Patients with acute deep vein thrombosis
  8. Metastasis and/or recurrence during treatment
  9. Patients who have undergone another surgery related to the breast and chest area
  10. Patients who develop lymphedema in the upper extremity during therapy will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Education, compression and exercise therapyEducation, compression and exercise therapyPatients will be given exercise therapy every day for the first two weeks. Afterwards, patients will be taken to the same therapy in the hospital for 1 day a week, and on other days they will do home exercise at home for 10 minutes.
Education, compression,exercise therapy and manual lymph drainageEducation, compression and exercise therapy manual lymph drainagePatients will be given manual lymph drainage for one and a half hours every day for the first two weeks. Afterwards, patients will be taken to the same therapy in the hospital for 1 day a week, and on other days they will do self manual lymph drainage at home for 10 minutes.
Primary Outcome Measures
NameTimeMethod
Breast edema questionnaireChange from baseline breast edema questionnaire at 12 weeks

Getting 8.5 points from the questionnaire is the cut-off point. There is no breast edema below 8.5, there is breast edema above 8.5. It has a score between 0-80 points.

Clinical features of breast cancer and breast edemaChange from baseline clinical features of breast cancer and breast edema at 12 weeks

The presence of breast fibrosis or edema, teleangiectasia or dyspigmentation will be scored on a 4-point categorical scale. The scale will be in the range of 0-16 points, high scores will indicate worsening of breast edema, and low scores will indicate improvement.

Qualitiy of Life - European Organization for Research and Treatment of Cancer EORTC- BR23Change from baseline Quality of life (EORTC- BR23) test at 12 weeks

The EORTC-BR23 is a breast-specific module that comprises of 23 questions to assess body image, sexual functioning, sexual enjoyment, future perspective, systemic therapy side effects, breast symptoms, arm symptoms and upset by hair loss.All scores will linearly transforme to a 0 to 100 scale. A high or healthy level of functioning is represented by a high functional score. More severe symptoms or problems are represented by high symptom scores or items.

LENT-SOMA criteria in breast edemaChange from baseline LENT-SOMA criteria at 12 weeks

Breast Cancer Conservative treatment core objective measurement. It has a score between 13-52 points. As the score increases, it is seen that breast edema worsens. A decrease in the score indicates improvement in breast edema.

Secondary Outcome Measures
NameTimeMethod
Breast pain intensity will be measured with the Visual Analog ScaleChange from baseline Visual Analog Scale test at 12 weeks

The scale is 10 cm long and is applied by specifying a point on the vertical or horizontal line with two different ends (0 = no pain, 10 = the most severe pain) corresponding to the severity of pain felt by the patient.

Quality of life test (EORTC QOL-C30)Change from baseline Quality of life test (EORTC QOL-C30) at 12 weeks

It includes 30 items that are grouped into five scales functional (physical, social, emotional functioning, cognitive and role), three scales of symptoms (fatigue, pain, nausea and vomiting), a global scale of health / quality of life and a number of related individual items with the symptoms of the disease and its treatment, as well as an item of economic impact. The answers to the items on the scales refer to "last week," except the patient's physical functioning scale whose time frame is the present. These answers they obey a Likert format, which ranges from 1 ("Not at all") and 4 ("A lot")

Trial Locations

Locations (1)

Acibadem University

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath